Refocus Group, Inc.
OTC: RFCS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- J. Michael Judy
- Employees
- 4
- Headquarters
- Dallas, United States
- IPO year
- 2003
- Market cap
- $25.0
- Website
- https://www.refocus-group.com
Loading RFCS…
Loading profile data…Frequently asked questions about RFCS
What does Refocus Group, Inc. (RFCS) do?
Refocus Group, Inc. is a medical technology firm dedicated to the research and creation of therapies for various human vision conditions, particularly presbyopia. A key offering is the VisAbility Micro-Insert System, an experimental medical device currently undergoing clinical evaluations for its application in treating presbyopia affecting both...
Where does RFCS trade?
Refocus Group, Inc. (RFCS) trades on the Other OTC.
What sector is RFCS in?
Refocus Group, Inc. (RFCS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Refocus Group, Inc.?
J. Michael Judy is the chief executive officer of Refocus Group, Inc. (RFCS).
Where is Refocus Group, Inc. headquartered?
Refocus Group, Inc. is headquartered in United States.
Does RFCS pay a dividend?
Refocus Group, Inc. (RFCS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RFCS go public?
Refocus Group, Inc. (RFCS) completed its initial public offering in 2003.